🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Really disappointed how slowly Europe (especially Germany) is moving these days Obviously, to compete with US/China on any relevant topic (AI / economy / defense), we need more European integration, joing funding, joint efforts - and much much faster more resources:

So proud of our new preprint "toolmaker" by Georg Wölflein et al.: AI Agents building AI agents.

It is happening. Pubmed (pubmed.gov) is gone. And so is cancer.gov. European science really needs to wake up. Technical info: tldr.nettime.org/@ww/1140899115…

Twitter used to be my favorite place on the Internet. I've derived enormous value from it in the past 16 years. Not true anymore. Most of the people I enjoyed reading have left. My feed, which used to feature art and science and technology and humor, has become constant

Good to see this in print. We built Orpheus, a model to infer OncoType score from H&E and pathology text reports, finding that multimodality strengthens inference. We also tuned directly on metastatic recurrence to refine TAILORx low/intermed. risk groups. nature.com/articles/s4146…

The European Interdisciplinary Society of AI for Cancer Research EU Interdisc. Society of AI for Cancer Research is official!! As a clinician AI enthusiast and very strong believer in the transformative power of AI approaches in cancer research, I am very happy to join a stellar Steering Committee of AI experts

Beyond ChatGPT and digital pathology algorithms, Jakob Nikolas Kather reviews current and future states for deep learning artificial intelligence in breast oncology #SGBCC2025

We have open Postdoc / PhD student positions in computational pathology and agentic AI, based in 🇩🇪🇪🇺 Ideally with a CS background, but we do 🧡 biologists with self-taught Python and ML skills

Happy to share our latest paper in NEJM AI , led by Isabella Wiest : "Deidentifying Medical Documents with Local, Privacy-Preserving Large Language Models: The LLM-Anonymizer" ai.nejm.org/doi/full/10.10… You can use our open source tool with local LLMs to robustly de-identify medical

Happy weekend from our research group "clinical AI" katherlab TU Dresden

Together with the ESMO - Eur. Oncology #RealWorldData group, the #PrecisionOncology working group is currently developing a framework on how to make #artificalintelligence #biomarkers ready for clinical use in #oncology - thanks to Jakob Nikolas Kather for spearheading this effort. #PrecisionMedicine

We are looking to hire a PostDoc at katherlab to develop AI multimodal foundation models for uncovering cancer metastasis mechanisms and identifying targetable biomarkers for patient treatment. 🩻🔬🧬 If you’re interested, please apply here: bit.ly/42nY62u

Exciting afternoon at the #AIforOncology Congress! Inspiring lectures on #LLMs in oncology, AI-driven #DrugDiscovery, and the future of #DigitalTwins in patient care. 🚀 Grateful to be part of a community pushing boundaries for better cancer outcomes! #OncologyAI #Innovation

EASLnews Ahmed Elsharkawy Jakob Nikolas Kather Ashley Spann Sabela Lens García Future-gazing 🧭: In 2 yrs, how will clinical & research practice change with #AI? ✅ Ability to study AI models in practice (w/ guidelines & rigorous testing) ✅ Easier data access for clinical decisions ✅ CE-marked AI tools coming → pressure to modernise (yes, some people

Very happy to share our new paper on LLM-based tumor board agents. Submitted August 2024, published in Nature Cancer today ☺️ Led by Dyke Ferber nature.com/articles/s4301…

Wow thanks for the shout-out 🤩 Eric Topol

The new tumour board? ⁦Nature Cancer⁩ - multimodel AI agent integrates patient data using GPT-4, MSI/KRAS/BRAF slides, radiologic images, OncoKB/PubMed/Google - AI agent makes correct clinical decision in 91% cases ⁦Jakob Nikolas Kather⁩ ⁦OncoAlert⁩ nature.com/articles/s4301…

Prof. Kather Jakob Nikolas Kather is presenting AI Agents in Oncology and Cancer Research! Welcome to join us! #CVPR2025

What's the path forward for AI in the cancer clinic? Our NEJM AI review explored this question. A new paper in Nature Cancer from Jakob Nikolas Kather's team now provides a compelling example with a "tool-using" AI agent. open.substack.com/pub/profelemen…

🤖 #ESMOAI25: Help us advance cancer care through technology 🚨 Your insights will help drive the evolution of AI and digital solutions in oncology. ⏰ Submit your research by 2 September 2025. #HealthAI 🔗 ow.ly/pjIQ50Wia3a